IgE Autoantibodies Directed Against the Major Bullous Pemphigoid Antigen in Patients with a Severe Form of Pemphigoid

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3642-3647

  Delaporte, Emmanuel ^a   Dubost Brama, Ariane ^a   Ghohestani, Reza ^b   Nicolas, Jean François ^c   Neyrinck, Jean Loup ^d   Bergoend, Henri ^a   Janin, Anne ^a   Capron, Monique ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BPAG1 PROTEIN, HUMAN; CARRIER PROTEIN; COLLAGEN; COLLAGEN TYPE 17; CYTOSKELETON PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; NERVE PROTEIN; NONFIBRILLAR COLLAGEN; RECOMBINANT PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; BLOOD; BULLOUS PEMPHIGOID; EOSINOPHIL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; PATHOPHYSIOLOGY; SKIN;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; COLLAGEN; CYTOSKELETAL PROTEINS; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; RECEPTORS, IGE; RECOMBINANT PROTEINS; SKIN;

EID: 0030587811     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Soussi Gounni, A., B. Lamkhioued, E. Delaporte, A. Dubost, J. P. Kinet, A. Capron, and M. Capron. 1994. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy? J. Allergy Clin. Immunol. 94:1214.
2. Capron, M., H. L. Spiegelberg, L. Prin, H. Bennich, A. E. Butterworth, R. J. Pierce, M. A. Ouaissi, and A. Capron. 1984. Role of IgE receptors in effector function of human eosinophils. J. Immunol. 132:462.
3. Tomassini, M., A. Tsicopoulos, P. C. Tai, V. Gruart, A. B. Tonnel, L. Prin, A. Capron, and M. Capron. 1991. Release of granule proteins by eosinophils from allergic and non allergic patients with eosinophilia on immunoglobulin-dependent activation. J. Allergy Clin. Immunol. 88:365.
4. Khalife, J., M. Capron, J. Y. Cesbron, P. C. Tai, H. Taelman, L. Prin, and A. Capron. 1986. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J. Immunol. 137:1659.
5. Capron, M., M. Tomassini, G. Torpier, J. P. Kusnierz, S. MacDonald, and A. Capron. 1989. Selectivity of mediators released by eosinophils. Int. Arch. Allergy Appl. Immunol. 88:54.
6. Capron, M., M. J. Truong, D. Aldebert, V. Gruart, M. Suemura, G. Delespesse, B. Tourvieille, and A. Capron. 1991. Heterogeneous expression of CD23 epitopes by eosinophils from patients: relationships with IgE-mediated functions. Eur. J. Immunol. 21:2423.
7. Soussi Gounni, A., B. Lamkhioued, K. Ochiai, Y. Tanaka, E. Delaporte, A. Capron, J. P. Kinet, and M. Capron. 1994. Expression of the high affinity immunoglobulin E receptor on eosinophils: involvement in immune defence against parasites. Nature 367:183.
8. Arbesman, C. E., J. I. Wypych, R. E. Reisman, and E. H. Beutner. 1974. IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch. Dermatol. 110:378.
9. Asbrink, E., and A. Hovmark. 1984. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies. Acta Dermatol. Venereol. 64:243.
10. Ownby, D. R. 1993. Clinical significance of IgE. In Allergy: Principles and Practice, 4th Ed., Vol. 2. E. Middleton Jr., C. E. Reed, E. F. Ellis, N. F. Adkinson, Jr., J. W. Yunginger, and W. W. Busse, eds. Mosby, St. Louis, p. 1059.
11. Stanley, J. R. 1989. Pemphigus and pemphigoid as paradigms of organ specific, autoAb-mediated diseases. J. Clin. Invest. 83:1443.
12. Stanley, J. R., T. Tanaka, S. Mueller, V. Klaus-Kovtun, and D. Roop. 1988. Isolation of complementary DNA for bullous pemphigoid antigen by use of patient's autoantibodies. J. Clin. Invest. 82:1864.
13. Diaz, L. A., H. Ratrie III, W. S. Saunders, S. Futamura, H. L. Squiquera, G. H. Anhalt, and C. J. Giudice. 1990. Isolation of a human epidermal cDNA corresponding to the 180 kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. J. Clin. Invest. 98:942.
14. Tamai, K., D. Sawamura, H. Y. Choi Do, K. Li, and J. Uitto. 1994. Molecular biology of the 230-kD bullous pemphigoid antigen. Dermatology 189:27.
15. Soh, H., H. Hosokawa, and Y. Asada. 1993. IgE and its related phenomena in bullous pemphigoid. Br. J. Dermatol. 128:371.
16. Parodi, A., and A. Rebora. 1992. Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid. Br. J. Dermatol. 126:526.
17. Nieboer, C., and H. J. E. Van Leeuven. 1980. IgE in the serum and on mast cell in bullous pemphigoid. Arch. Dermatol. 116:555.
18. Dubertret, L., B. Bertaux, M. Fosse, and R. Touraine. 1980. Cellular events leading to blister formation in bullous pemphigoid. Br. J. Dermatol. 103:615.
19. Goldstein, S. M., S. I. Wassermann, and B. U. Wintroub. 1989. Mast cell and eosinophil mediated damage in bullous pemphigoid. Immunol. Ser. 46:527.
20. Scheman, A. J., M. D. Hordinsky, D. W. Groth, G. M P. Vercellotti, and K. M. Leiferman. 1989. Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis. Arch. Dermatol. 125:1079.
21. Cox, N. H., P. N. Cooper, P. Venge, and P. S. Friedmann. 1993. Eosinophil cationic protein in bullous pemphigoid, dermatitis herpetiformis and other blistering disorders. Eur. J. Dermatol. 3:294.
22. Stahle-Backdahl, M., M. Inoue, G. J. Giudice, and C. W. Parks. 1994. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J. Clin. Invest. 93:2022.
23. Sams, W. M., Jr., and R. E. Jordon. 1971. Correlation of pemphigoid and pemphigus Ab titers with activity of disease. Br. J. Dermatol. 84:7.
24. Bernard, P., J. Venot, F. Constant, and J. M. Bonnetblanc. 1987. Blood eosinophilia as a severity marker for bullous pemphigoid. J. Am. Acad. Dermatol. 10: 879.
25. Machado, P., H. Michalaki, P. Roche, M. Gaucherand, J. Thivolet, and J. F. Nicolas. 1992. Serological diagnosis of bullous pemphigoid (BP): comparison of the sensitivity of indirect immunofluorescence on salt-split skin to immunoblotting. Br. J. Dermatol. 126:236.
26. Hansel, T. T., J. D. Pound, D. Pilling, G. D. Kitas, M. Salmon, T. A. Gentle, S. S. Lee, and R. A. Thompson. 1989. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J. Immunol. Methods 122:97.
27. Gaucherand, M., J. F. Nicolas, G. Paranhos Baccala, J. P. Rouault, A. Réano, J. P. Magaud, J. Thivolet, M. Jolivet, and D. Schmitt. 1995. Major antigenic epitopes of bullous pemphigoid 230 kDA antigen map within the C-terminal end of the protein: evidence using a 55kDa recombinant protein. Br. J. Dermatol. 132:190.
28. Provost, T. T., and T. B. Tomasi Jr. 1974. Immunopathology of bullous pemphigoid: basement membrane deposition of IgE, alternate pathway components and fibrin. Clin. Exp. Immunol. 18:193.
29. Baba, T., H. Sonozaki, K. Seki, M. Uchiyama, Y. Ikesawa, and M. Torisu. 1976. An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients. J. Immunol. 116:112.
30. Razzaque Ahmed, A., J. C. Maize, and T. T. Provost. 1977. Bullous pemphigoid: clinical and immunologic follow-up after successful therapy. Arch. Dermatol. 113:1043.
31. Huilgol, S. C., B. S. Bhogal, and M. M. Black. 1995. Immunofluorescence of the immunobullous disorders. Eur. J. Dermatol. 5:186.
32. Bird, P., P. S. Friedmann, N. Ling, A. G. Bird, and R. A. Thompson. 1986. Subclass distribution of IgG autoantibodies in bullous pemphigoid. J. Invest. Dermatol. 86:21.
33. Hadi, S. M., R. StC. Barnetson, D. J. Gawkrodger, U. Saxena, P. Bird, and T. G. Merrett. 1988. Clinical, histological and immunological studies in 50 patients with bullous pemphigoid. Dermatologica 176:6.
34. Giudice, G. J., K. C. Wilske, G. J. Anhalt, J. A. Fairley, A. F. Taylor, D. J. Emery, R. G. Hoffman, and L. A. Diaz. 1994. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J. Invest. Dermatol. 102:878.
35. Czech, W., J. Schaller, E. Schöpf, and A. Kapp. 1993. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J. Am. Acad. Dermatol. 29:210.
36. Tanaka, Y., M. Takenaka, Y. Matsunaga, S. Okada, S. Anan, H. Yoshida, and C. Ra. 1995. High affinity IgE receptor (FcεRI) expression on eosinophils infiltrating the lesions and mite patch tested sites in atopic dermatitis. Arch. Dermatol. Res. 287:712.
37. Dubucquoi, S., P. Desreumaux, A. Janin, O. Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin-5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703.
38. Endo, H., I. Iwamoto, M. Fujita, S. Okamoto, and S. Yoshida. 1992. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid. Arch. Dermatol. Res. 284:312.
39. Lamkhioued, B., D. Aldebert, A. Soussi Gounni, E. Delaporte, M. Goldman, A. Capron, and M. Capron. 1995. Synthesis of cytokines by eosinophils and their regulation. Int. Arch. Allergy Immunol. 107:122.
40. Tanaka, Y., E. Delaporte, S. Dubucquoi, A. Soussi Gounni, E. Porchet, A. Capron, and M. Capron. 1994. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J. Invest. Dermatol. 103:589.
41. Soh, H., H. Hosokawa, H. Miyauchi, H. Izumi, and Y. Asada. 1991. The distribution of IgG subclass autoantibodies in bullous pemphigoid analysed by immunofluorescence and immunoblotting. Arch. Dermatol. Res. 283:400.
42. Goldman, M., P. Druet, and E. Gleichmann. 1991. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today 12:223.
43. Nagpal, S., P. Sriramarao, P. R. Krishnaswamy, D. D. Metcalfe, and P. V. Subba Rao. 1990. Demonstration of IgE antibodies to nucleic acid antigens in patients with SLE. Autoimmunity 8:59.
44. Burastero, S. E., G. Lo Pinto, D. Goletti, M. Cutolo, L. Burlando, and P. Falagiani. 1993. Rheumatoid arthritis with monoclonal IgE rheumatoid factor. J. Rheumatol. 20:489.
45. Raikow, R. B., A. Tyutyunikov, J. S. Kennerdell, M. Kazim, M. H. Dalbow, and D. Scalise. 1992. Correlation of serum immunoglobulin E elevations with clinical stages of dysthyroid orbitopathy. Ophthalmology 99:361.